Claudine Isaacs

Also affiliated with University Hospital Ulm

Biochemistry, Genetics and Molecular BiologyMedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

7.4Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

Cancer Cell(2022)10.1016/j.ccell.2022.05.005

Top 4%

4.9DataRank

Top 4%329 citations

Christina Yau, Julia Wulfkuhle, Lamorna Brown Swigart, Rosa I. Gallagher, Pei Rong Evelyn Lee +28 more

Papers

Driven by 70 papers — median percentile 91. Top paper: “Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer”.

Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

JAMA Oncology(2020)10.1001/jamaoncol.2020.2535

N/A

6.3DataRank · unranked

225 citations

Angela DeMichele, Christina Yau, Claudine Isaacs, W. Fraser Symmans, Kathy S. Albain +74 more

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

Cancer Cell(2022)10.1016/j.ccell.2022.05.005

Top 4%

4.9DataRank

Top 4%329 citations

Christina Yau, Julia Wulfkuhle, Lamorna Brown Swigart, Rosa I. Gallagher, Pei Rong Evelyn Lee +28 more

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

Nature Cancer(2022)10.1038/s43018-022-00491-x

Top 9%

2.4DataRank

Top 9%114 citations

Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual +53 more

Applying a Life Course Biological Age Framework to Improving the Care of Individuals With Adult Cancers

JAMA Oncology(2021)10.1001/jamaoncol.2021.1160

N/A

1.5DataRank · unranked

51 citations

Tim A. Ahles, Marc E. Lippman, Claudine Isaacs, Lucile L. Adams‐Campbell, Andrew J. Saykin +3 more

Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature Medicine(2024)10.1038/s41591-024-03267-1

N/A

1.4DataRank · unranked

43 citations

Meghna S. Trivedi, Christina Yau, Rita Nanda, Hope S. Rugo, Marie Davidian +55 more

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer

JAMA Oncology(2023)10.1001/jamaoncol.2022.7949

N/A

1.4DataRank · unranked

52 citations

Vera J. Suman, Antonino B. D’Assoro, Jodi M. Carter, Karthik V. Giridhar, Brendan P. McMenomy +18 more

Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer

JAMA Oncology(2023)10.1001/jamaoncol.2023.5424

N/A

0.911DataRank · unranked

34 citations

Vandana G. Abramson, Elizabeth Claire Dees, Payal D. Shah, Tarah J. Ballinger, Claudine Isaacs +12 more

Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00493-z

N/A

0.900DataRank · unranked

27 citations

Andres Forero‐Torres, Douglas Yee, Christina Yau, Denise M. Wolf, John Park +44 more

Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature Medicine(2024)10.1038/s41591-024-03266-2

N/A

0.610DataRank · unranked

13 citations

Jane Meisel, Christina Yau, Hope S. Rugo, Rita Nanda, Marie Davidian +52 more

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

Communications Biology(2022)10.1038/s42003-022-03978-6

N/A

0.607DataRank · unranked

15 citations

John F. Pearson, Louise Marquart, Joe Dennis, George A. R. Wiggins, Daniel R. Barnes +95 more

Physical activity and cognition: longitudinal findings from the Thinking and Living with Cancer Study

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae182

N/A

0.265DataRank · unranked

4 citations

Xingtao Zhou, Danielle B. Tometich, Brent J. Small, Tim A. Ahles, Jaeil Ahn +18 more

Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07555-9

N/A

0.255DataRank · unranked

4 citations

Mike Campbell, Christina Yau, A. Jo Chien, Anne M. Wallace, Claudine Isaacs +18 more

Streamlined Genetic Education and Cascade Testing in Men from Hereditary Breast Ovarian Cancer Families: A Randomized Trial

Public Health Genomics(2024)10.1159/000540466

N/A

0.249DataRank · unranked

4 citations

Beth N. Peshkin, Lia Sorgen, Claudine Isaacs, Mary Kathleen Ladd, Aryana Jacobs +10 more

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

Cancer Cell(2021)10.1016/j.ccell.2021.05.009

N/A

0DataRank · unranked

335 citations

Christina Yau, Denise M. Wolf, Hyo S. Han, Lili Du, Anne M. Wallace +40 more

Evaluating the impact of age on immune checkpoint therapy biomarkers

Cell Reports(2021)10.1016/j.celrep.2021.109599

N/A

0DataRank · unranked

80 citations

Zheyu Wang, Sharon Wu, Joanne Xiu, Neeha Zaidi, Jennifer La +20 more

Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial

Nature Communications(2021)10.1038/s41467-021-26019-y

N/A

0DataRank · unranked

73 citations

Christina Yau, Denise M. Wolf, Emanuel F. Petricoin, L. J. van ‘t Veer, Douglas Yee +46 more

Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2−) breast cancer before chemo-endocrine therapy

Annals of Oncology(2021)10.1016/j.annonc.2021.02.011

N/A

0DataRank · unranked

45 citations

Christina Yau, Lamorna Brown Swigart, Rebekah Gould, Gregor Krings, Gillian L. Hirst +27 more

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

npj Breast Cancer(2021)10.1038/s41523-021-00337-2

N/A

0DataRank · unranked

29 citations

Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska, Karthik V. Giridhar +50 more

Analysis of immune checkpoint blockade biomarkers in elderly patients using large-scale cancer genomics data.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2543

N/A

0DataRank · unranked

3 citations

Zheyu Wang, Sharon Wu, Joanne Xiu, Neeha Zaidi, Marc E. Lippman +12 more

Molecular characterization of the Ras-MAPK pathway in metastatic breast cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.1034

N/A

0DataRank · unranked

2 citations

Jun Yin, Joanne Xiu, W. Michael Korn, Heinz‐Josef Lenz, Gino K. In +14 more

A simulation model-based clinical decision tool to guide personalized treatment based on individual characteristics: Does 21-gene recurrence score assay testing change decisions?

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e12507

N/A

0DataRank · unranked

0 citations

Joseph A. Sparano, Young Chandler, Claudine Isaacs, Allison W. Kurian, Lawrence H. Kushi +4 more

Elevated C-Reactive Protein and Subsequent Patient-Reported Cognitive Problems in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study

Journal of Clinical Oncology(2022)10.1200/jco.22.00406

N/A

0DataRank · unranked

42 citations

Zev M. Nakamura, Brent J. Small, Xingtao Zhou, Harvey Jay Cohen, Tim A. Ahles +18 more

Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06623-2

N/A

0DataRank · unranked

14 citations

Xingtao Zhou, Jaeil Ahn, Brent J. Small, Wanting Zhai, Traci N. Bethea +17 more

Long-Term Adaptation Among Adolescent and Young Adult Children to Familial Cancer Risk

PEDIATRICS(2022)10.1542/peds.2022-056339

N/A

0DataRank · unranked

5 citations

Beth N. Peshkin, Tiffani A. DeMarco, Susan K. Peterson, Banu Arun, Susan Miesfeldt +7 more

Multiplatform Analysis of Primary and Metastatic Breast Tumors from the AURORA US Network identifies microenvironment and epigenetics drivers of metastasis

Research Square(2022)10.21203/rs.3.rs-1221704/v1

N/A

0DataRank · unranked

2 citations

Susana García‐Recio, Toshinori Hinoue4, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro +49 more

Association of Markers of Tumor Aggressivity and Cognition in Women with Breast Cancer Before Adjuvant Treatment: The Thinking and Living with Cancer Study

Research Square(2022)10.21203/rs.3.rs-1506459/v1

N/A

0DataRank · unranked

1 citations

Xingtao Zhou, Jaeil Ahn, Brent J. Small, Wanting Zhai, Traci N. Bethea +17 more

Molecular subtype to predict pathologic complete response in HER2-positive breast cancer in the I-SPY2 trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.510

N/A

0DataRank · unranked

1 citations

Amy S. Clark, Christina Yau, Denise M. Wolf, L. J. van ‘t Veer, Emily Douglas +10 more

Simulation modeling as a tool to support clinical guidelines and care for breast cancer prevention and early detection in high-risk women.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10525

N/A

0DataRank · unranked

0 citations

Kathryn P. Lowry, Jennifer M. Yeh, Marc D. Schwartz, Karen J. Wernli, Claudine Isaacs +3 more

Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy

Cancer Cell(2023)10.1016/j.ccell.2023.04.008

N/A

0DataRank · unranked

175 citations

Lamorna Brown Swigart, Ziad Ahmed, Rosalyn W. Sayaman, Derrick Renner, Ekaterina Kalashnikova +26 more

NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0519

N/A

0DataRank · unranked

65 citations

Xiaopeng Sun, Paula I. González-Ericsson, Violeta Sánchez, Melinda E. Sanders, Elizabeth C. Wescott +15 more

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2256

N/A

0DataRank · unranked

20 citations

Christina Yau, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien +44 more

Plasma levels of interleukin‐6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study

Cancer(2023)10.1002/cncr.34784

N/A

0DataRank · unranked

18 citations

Brent J. Small, Xingtao Zhou, Zev M. Nakamura, Harvey Jay Cohen, Tim A. Ahles +18 more

Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101312

N/A

0DataRank · unranked

18 citations

Julia Wulfkuhle, Denise M. Wolf, Lamorna Brown Swigart, Christina Yau, Nicholas O’Grady +22 more

BRCA1 deficiency in mature CD8+ T lymphocytes impairs antitumor immunity

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005852

N/A

0DataRank · unranked

15 citations

Leilei Qi, Huai-Chin Chiang, Haihui Pan, Xiaowen Zhang, Alexandra Z. Greenbaum +11 more

An 8-week exercise study to improve cancer treatment related fatigue and QOL among African American breast cancer patients undergoing radiation treatment: A pilot randomized clinical trial

Journal of the National Medical Association(2023)10.1016/j.jnma.2023.01.011

N/A

0DataRank · unranked

14 citations

Jennifer L. Hicks, Kepher H. Makambi, Pamela Randolph-Jackson, Mary Mills, Claudine Isaacs +2 more

Measuring high‐risk parents' opinions about direct‐to‐consumer genetic testing for adult‐onset inherited cancer syndromes in their adolescent and young adult children

Journal of Genetic Counseling(2023)10.1002/jgc4.1685

N/A

0DataRank · unranked

3 citations

Beth N. Peshkin, Jada G. Hamilton, Jamie Brower, Hannah Ovadia, Lainie Friedman Ross +10 more

Results of a randomized controlled trial of a decision support intervention for disclosing maternal BRCA genetic test results to children and adolescents

PEC Innovation(2023)10.1016/j.pecinn.2023.100129

N/A

0DataRank · unranked

3 citations

Tiffani A. DeMarco, Katherine A. Schneider, George Luta, Claudine Isaacs, Judy E. Garber +4 more

355P Reduction of anthracycline use with a combined imaging and pathology prediction model in the neoadjuvant I-SPY2 trial

Annals of Oncology(2023)10.1016/j.annonc.2023.09.534

N/A

0DataRank · unranked

2 citations

Elizabeth Price, Sara J. Venters, Wěi Li, Denise M. Wolf, Jessica Gibbs +14 more

Oral paclitaxel and dostarlimab with or without trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant ISPY 2 TRIAL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.17_suppl.lba612

N/A

0DataRank · unranked

2 citations

Alexandra Thomas, Christina Yau, A. Jo Chien, Carla I. Falkson, Erica Stringer-Reasor +15 more

Oral paclitaxel, carboplatin, and dostarlimab (OPE/Cb/D) without and with trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.17_suppl.lba520

N/A

0DataRank · unranked

2 citations

Kevin Kalinsky, Christina Yau, A. Jo Chien, Judy C. Boughey, Erica Stringer-Reasor +15 more

Streamlining regulatory review in a multicenter platform trial: Opportunity to enhance patient centered care and drive innovation and efficiency.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1572

N/A

0DataRank · unranked

1 citations

Teresa Helsten, Brian Moore, Linda Neuhauser, Barbara LeStage, Paolo Castillo +12 more

885 Characterization of the tumor microenvironment in advanced breast cancer patients treated with talazoparib followed by combination of talazoparib and avelumab

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0885

N/A

0DataRank · unranked

1 citations

Filipa Lynce, Xue Geng, Edward T. Richardson, Candace Mainor, Mei Wei +14 more

Data from Modification of Ovarian Cancer Risk by BRCA1/2-Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers

(2023)10.1158/0008-5472.c.6499160.v1

N/A

0DataRank · unranked

0 citations

Nandita Mitra, Susan M. Domchek, Fei Wan, Shannon Chuai, Tara M. Friebel +22 more

Pathologic complete response (pCR) rates for patients with HR+/HER2− high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial

Annals of Oncology(2024)10.1016/j.annonc.2024.10.018

N/A

0DataRank · unranked

26 citations

David S. Wolf, Christina Yau, Lamorna Brown Swigart, Gillian L. Hirst, Claudine Isaacs +15 more

Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07551-z

N/A

0DataRank · unranked

12 citations

H. Boutrid, Mahmoud Kassem, Mahmoud Abdel‐Rasoul, Cynthia Timmers, Maryam B. Lustberg +19 more

A scoping review of web-based, interactive, personalized decision-making tools available to support breast cancer treatment and survivorship care

Journal of Cancer Survivorship(2024)10.1007/s11764-024-01567-6

N/A

0DataRank · unranked

13 citations

Dalya Kamil, Julia Zhang, Oliver W.A. Wilson, Laney Smith, Gisela Butera +4 more

Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA study

npj Breast Cancer(2024)10.1038/s41523-024-00692-w

N/A

0DataRank · unranked

1 citations

Dylan M. Smith, Cody Peer, Tristan M. Sissung, Keith T. Schmidt, Ming Tan +16 more

Association of germline polygenic risk for thyroid autoimmunity with overall survival in the I-SPY2 Trial.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.10600

N/A

0DataRank · unranked

0 citations

Pooja Middha, Zoe Quandt, Yiwey Shieh, Amrita Basu, Rosalyn W. Sayaman +11 more

Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies

UNC Libraries(2024)10.17615/pxbw-z162

Top 100%

0DataRank

Top 100%0 citations

Graham G. Giles, Louise A. Brinton, Elisabete Weiderpass, Brian D. Carter, Lesley M. Butler +21 more

Pharmacokinetics and Pharmacogenomics of Ribociclib in Black Patients with Metastatic Breast Cancer: The LEANORA study

Research Square(2024)10.21203/rs.3.rs-4656461/v1

N/A

0DataRank · unranked

0 citations

Ilana Schlam, Dylan M. Smith, Cody Peer, Tristan M. Sissung, Keith T. Schmidt +16 more

Effects of personal cancer history and genomic risk information on mothers’ psychological adaptation to inherited breast/ovarian cancer syndrome

Psychology Health & Medicine(2024)10.1080/13548506.2024.2417311

N/A

0DataRank · unranked

0 citations

Marcelo M. Sleiman, Mary Rose Yockel, Beth N. Peshkin, Jessica J. Chiang, Claudine Isaacs +2 more

Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors

Nature Communications(2025)10.1038/s41467-025-65432-5

N/A

0DataRank · unranked

6 citations

Nayelis A. Manon, Denise M. Wolf, Samuel Rivero-Hinojosa, Ziad Ahmed, Rosalyn W. Sayaman +20 more

Parental Communication With their Children about Cancer Risk and DTC Cascade Genetic Testing: Implications for Genetic Education and Counseling

American Journal of Medical Genetics Part A(2025)10.1002/ajmg.a.64115

N/A

0DataRank · unranked

2 citations

Talia Zamir, Beth N. Peshkin, Jada G. Hamilton, Mingqian Liu, Mary Rose Yockel +10 more

Pediatric DTC Genetic Testing for Adult-Onset Inherited Cancer Risk: The Perspectives of High-Risk Parents

Public Health Genomics(2025)10.1159/000543913

N/A

0DataRank · unranked

1 citations

Beth N. Peshkin, Jada G. Hamilton, Jamie Brower, Hannah Ovadia, Lainie Friedman Ross +12 more

Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial

Annals of Surgical Oncology(2025)10.1245/s10434-025-17864-y

N/A

0DataRank · unranked

1 citations

Katrina Dimitroff, Judy C. Boughey, Laura J. Esserman, Christina Yau, Julia Tchou +34 more

Physical Activity and Cognition: Longitudinal findings from the Thinking and Living with Cancer Study

UNC Libraries(2025)10.17615/d0qv-np06

N/A

0DataRank · unranked

0 citations

Andrew J. Saykin, Elizabeth C. Breen, Xingtao Zhou, Brent J. Small, Kathleen Van Dyk +18 more

Longitudinal Quality of Life in Adults with Metastatic Breast Cancer: The Impact of Between- and Within-Person Changes in Symptoms and Positive Affect

Research Square(2025)10.21203/rs.3.rs-8138106/v1

N/A

0DataRank · unranked

0 citations

Brent J. Small, Elizabeth L. Addington, Judith T. Moskowitz, Mikaela A. Velazquez-Sosa, Jennifer D. Rodriguez +13 more

BDNF genotype and cognition in older adults with breast cancer and healthy controls in the Thinking and Living with Cancer Study

Journal of Geriatric Oncology(2025)10.1016/j.jgo.2025.102834

N/A

0DataRank · unranked

0 citations

Brent J. Small, Xingtao Zhou, Jaeil Ahn, Tim A. Ahles, Ashley Artese +16 more

Characterization of the Cancer Spectrum in Men With GermlineBRCA1andBRCA2Pathogenic Variants

JAMA Oncology(2020)10.1001/jamaoncol.2020.2134

N/A

0DataRank · unranked

67 citations

Goska Leslie, Daniel R. Barnes, and the CIMBA Group, Bjarni A. Agnarsson, Kristiina Aittomäki +95 more

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

UNC Libraries(2020)10.17615/bg56-kz70

N/A

0DataRank · unranked

19 citations

Trinidad Caldés, Maria A. Caligo, Alessandra Viel, Susan J. Ramus, Kathleen Claes +95 more

Trends in the Use of Cardiac Imaging for Women with Newly Diagnosed Breast Cancer

Journal of Cardiovascular Translational Research(2020)10.1007/s12265-020-10023-6

N/A

0DataRank · unranked

11 citations

Claudine Isaacs, Nawar Shara, Filipa Lynce, Sameer Desale, Kevin Haynes +2 more

Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12069

N/A

0DataRank · unranked

0 citations

Ana Barac, Filipa Lynce, Xue Geng, Chau T. Dang, Anthony F. Yu +13 more

A planned, prospective comparison of short-term quality of life outcomes among older patients with breast cancer treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB #49907 and #369901

UNC Libraries(2020)10.17615/1pye-6424

N/A

0DataRank · unranked

0 citations

Arti Hurria, Clifford A. Hudis, Luta, Gheorghe, Hyman B. Muss, Jeanne S. Mandelblatt +8 more

Large Prospective Study of Ovarian Cancer Screening in High-Risk Women: CA125 Cut-Point Defined by Menopausal Status

UNC Libraries(2020)10.17615/6wxj-0g75

N/A

0DataRank · unranked

0 citations

Claudine Isaacs, Patrick M. Sluss, Phuong Mai, Wendy R. Brewster, Gustavo C. Rodriguez +25 more

Frailty and Adherence to Adjuvant Hormonal Therapy in Older Women With Breast Cancer: CALGB Protocol 369901

UNC Libraries(2020)10.17615/5sdb-jh20

N/A

0DataRank · unranked

0 citations

Claudine Isaacs, Gretchen Kimmick, Vanessa B. Sheppard, Michelle Tallarico, Eric P. Winer +12 more

Impact of genomic testing and patient-reported outcomes on receipt of adjuvant chemotherapy

UNC Libraries(2020)10.17615/g24t-9j94

N/A

0DataRank · unranked

0 citations

Noel T. Brewer, Suzanne C. O’Neill, Claudine Isaacs, Marc Boisvert, Susan T. Vadaparampil +4 more

Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis

UNC Libraries(2020)10.17615/7epw-8t59

N/A

0DataRank · unranked

0 citations

Eunjung Lee, Patricia G. Moorman, Dianne M. Finkelstein, P. Kelly Marcom, Banu Arun +15 more

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials

UNC Libraries(2020)10.17615/2xde-se42

N/A

0DataRank · unranked

0 citations

Phuong L. Mai, David S. Alberts, William J. Welch, Carol J. Fabian, Mary B. Daly +32 more

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients

The Lancet Oncology(2021)10.1016/s1470-2045(21)00589-1

N/A

0DataRank · unranked

447 citations

Marie Osdoit, Marieke van der Noordaa, Sonal Shad, Jane Wei, Diane de Croze +94 more

Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion

Nature(2021)10.1038/s41586-021-04057-2

N/A

0DataRank · unranked

403 citations

Bogang Wu, Huai-Chin Chiang, Hui Deng, Xiaowen Zhang, Wei Xiong +26 more

Claudine Isaacs

Indexed papers

Top data-sharing exemplar

Papers